Last reviewed · How we verify

NCT06062472

Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly

Completed NA Last updated 16 October 2024
What this trial tests

NA trial testing Probiotics in Elderly in 119 participants. Completed in 31 December 2023.

Timeline
8 August 2023
Primary endpoint
30 November 2023
31 December 2023

Quick facts

Lead sponsorChi-Chang Huang
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment119
Start date8 August 2023
Primary completion30 November 2023
Estimated completion31 December 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chi-Chang Huang

Who can join

Adults 65 to 85, any sex, with Elderly or Muscle Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study refers to the supplementation of PS23 in human experiments to help the elderly maintain muscle mass, delay muscle loss, promote physical activity, and delay the occurrence of disability and debilitation in elderly people.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Enhancement of Lower Limb Muscle Strength and Reduction of Inflammation in the Elderly: A Randomized, Double-Blind Clinical Trial Comparing <i>Lacticaseibacillus paracasei</i> PS23 Probiotic with Heat-Treated Supplementation.
    Lee MC, Hsu YJ, Yang HJ, Huang CC. · · 2025 · cited 10× · PMID 39940321 · DOI 10.3390/nu17030463

Verify or expand the search:

Other trials of Probiotics

Trials testing the same drug.

Other recruiting trials for Elderly

Currently open trials in the same condition.

Other Chi-Chang Huang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06062472.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing